Showing 2931-2940 of 23149 results for "".
Transplant & Treatment Options for Patients with Hepatocellular Carcinoma
https://reachmd.com/programs/advances-in-transplantation/transplant-and-treatment-options-for-patients-with-hepatocellular-carcinoma/6402/While the incidence of many types of cancer in the United States has decreased in recent years, the incidence of hepatocellular carcinoma, secondary to either hepatitis B or cirrhosis, has been on the rise. And, of the treatment options including resection, ablation and transplantation, what tumor cEmerging Therapies in Pediatric Atopic Dermatitis: Efficacy and Safety
https://reachmd.com/programs/dermconsult/emerging-therapies-in-pediatric-atopic-dermatitis-efficacy-and-safety/36441/Recent advances in nonsteroidal topicals and targeted biologics are expanding treatment options for pediatric atopic dermatitis. With more options now available, ongoing research comparing efficacy, safety, and long-term outcomes will be key to optimizing care. Hear Dr. Nicole Harter, Associate ProfThe Road Ahead – Integrating Research Into Practice
https://reachmd.com/programs/cme/The-Road-Ahead-Integrating-Research-Into-Practice/35973/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.Understanding Your Student Loans
https://reachmd.com/programs/your-money-your-life-financial-advice-for-physicians/understanding-your-student-loans/8134/Paying down student loans is the number one issue on the minds of many young physicians. Join Jim Hemphill, CERTIFIED FINANCIAL PLANNER™ and co-founder of TGS Financial Advisors, to learn some basic questions to ask and answer about your loans as you begin to construct your own optimal loan-managemeAdvancing Care for Women With Aortic Stenosis*: 2-Year Outcomes for Women in the 5-Year SMART Trial
https://reachmd.com/clinical-practice/cardiology/advancing-care-for-women-with-aortic-stenosis-2-year-outcomes-for-women-in-the-5-year-smart-trial/39669/Two-year SMART data show differences in valve performance and hemodynamics that may inform your treatment of women with AS and small annuli.New Guidelines for H. pylori Treatment: 2024 Updates from ACG
https://reachmd.com/programs/gi-insights/new-guidelines-for-h-pylori-treatment-2024-updates-from-acg/27079/Tune in to hear the newest recommendations for H. pylori treatment from the American College of Gastroenterology.Improving Diagnosis of Castleman Disease: The Key Role of Stromal Cells
https://reachmd.com/programs/project-oncology/improving-diagnosis-of-castleman-disease-the-key-role-of-stromal-cells/26400/Discover how stromal cells can inform new diagnostic methods and therapeutic strategies for Castleman disease.Assessing Adverse Pregnancy Outcomes in Isolated Sjögren’s Disease
https://reachmd.com/programs/living-rheum/assessing-adverse-pregnancy-outcomes-in-isolated-sjogrens-disease/36340/The systemic features of Sjögren’s disease may influence pregnancy outcomes, but specific obstetric complications are not very well understood. However, a recent retrospective cohort study analyzed them in patients with isolated Sjögren’s disease to shed more light on this research gap. Tune in to lUnderstanding the Full Spectrum and Burden of Multi-Food Allergies
https://reachmd.com/programs/frontlines-food-allergies/understanding-the-full-spectrum-and-burden-of-multi-food-allergies/26319/How can we address the high burden of multi-food allergies affecting nearly half of individuals with food allergies in the US? Tune in to find out.Shared Financial Incentives for Both Physicians and Patients Improved Cholesterol Levels
https://reachmd.com/programs/the-jama-report/shared-financial-incentives-both-physicians-and-patients-improved-cholesterol-levels/7744/[Read the Article] Financial incentives for physicians or patients are one way healthcare organizations are trying to improve health outcomes. A new study examined whether providing these financial incentives would help improve low-density lipoprotein cholesterol (LDL-C) in patients with a high-risk